Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
5000 participants
OBSERVATIONAL
2017-01-31
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study
NCT02420808
Prognostic Models for People With Stable Coronary Artery Disease
NCT01609465
An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study
NCT01061086
Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)
NCT00005160
Epidemiology of Cardiovascular Diseases in The Elderly
NCT00005186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Age \> 50 years volunteers (2 towns of 15000 residents one in the north and one in the south of Greece)
* End points
* 5-10 years cardiovascular morbidity and mortality
Measurements at baseline
* Anthropometrics
* Age (M\>55 years; W\>65 years)
* Weight-height- BMI
* Abdominal obesity (Waist circumference\>102 cm(M), \>88cm (W) Family history
* Family history of premature CV disease (M at age\<55 years; W at age\<65 years)
History
* Smoking
* Diabetes Mellitus,
* Established Heart disease: myocardial infarction; angina; coronary revascularization; heart failure
* Established renal disease \[diabetic nephropathy; renal impairment (serum creatinine M\>133, W\>124 mmol/l); proteinuria (\> 300 mg/24 h)\]
* Cerebrovascular disease: ischaemic stroke; cerebral haemorrhage; transient ischaemic attack
* Peripheral artery disease
* Advanced retinopathy: haemorrhages or exudates, papilloedema
* Treatment
Measurements
* Measurements Blood pressure
* Clinic BP
* 24h ABPM
* Home BP
Heart
* Electrocardiographic LVH
* Echocardiographic LVH
Vessels
* Carotid wall thickening or plaque
* Carotid-femoral pulse wave velocity
* Ankle/brachial BP index
Lipids or other risk factors
* Total cholesterol, Tg, HDL, LDL
* Plasma creatinine, estimated glomerular filtration rate
* Fasting plasma glucose or postload plasma glucose
* Microalbuminuria and albumin-creatinine ratio
* Glucose tolerance test
* Follow up each 3 year with all the above measurements
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vasilios Kotsis
Prof. Med
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vasilios Kotsis, Prof
Role: STUDY_CHAIR
AUTH
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUTH20090609
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.